[Commentary on] The OPTIMA study: assessing a new cinacalcet (sensipar/mimpara) treatment algorithm for secondary hyperparathyroidism.
Background and objective: Cinacalcet, a novel calcimimetic, targets the calcium-sensing receptor to lower parathyroid hormone (PTH), calcium, and phosphorus levels in dialysis patients with secondary hyperparathyroidism (SHPT). This study compared the efficacy of a cinacalcet-based regimen with unre...
| Publicado en: | Indian Journal of Nephrology Vol. 18; no. 1; pp. 42 - 43 |
|---|---|
| Formato: | abstract commentary Journal Article |
| Publicado: |
Scientific Scholar LLC
Jan-Mar2008
|
| Acceso en línea: | Ver este registro en EBSCOhost |